Detalhe da pesquisa
1.
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96â weeks of RETROBIC Study.
J Antimicrob Chemother;
79(3): 595-607, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38267266
2.
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
J Antimicrob Chemother;
78(7): 1658-1666, 2023 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37260299
3.
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
BMC Infect Dis;
23(1): 286, 2023 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142994
4.
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.
Int J Mol Sci;
23(19)2022 Sep 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36232381
5.
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19.
Nutr Metab Cardiovasc Dis;
31(9): 2619-2627, 2021 08 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34353699
6.
Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality.
Mediators Inflamm;
2021: 6637227, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33776574
7.
Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score.
Int J Clin Pract;
72(12): e13275, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30375125
8.
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Antimicrob Agents Chemother;
61(11)2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28874376
9.
A predictive model of immune recovery for DTGâ+â3TC and DTGâ+âRPV used as switching strategies in HIV+ patients.
J Antimicrob Chemother;
77(12): 3519-3523, 2022 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36245072
10.
Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
Enferm Infecc Microbiol Clin;
34(2): 122-31, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26474709
11.
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
Enferm Infecc Microbiol Clin;
33(1): 41-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25096166
12.
[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus]. / Documento de consenso sobre alteraciones metabólicas y riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana.
Enferm Infecc Microbiol Clin;
33(1): 40.e1-40.e16, 2015 Jan.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-25176009
13.
Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".
Antimicrob Agents Chemother;
62(1)2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29269435
14.
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV).
J Clin Med;
12(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36769822
15.
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
Viruses;
15(2)2023 01 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36851536
16.
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.
Drug Des Devel Ther;
16: 827-841, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35370401
17.
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection.
AIDS;
36(15): 2171-2179, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36382436
18.
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Medicine (Baltimore);
101(24): e29252, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35713430
19.
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Med Clin (Barc);
158(7): 315-323, 2022 04 08.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-34088524
20.
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Med Clin (Engl Ed);
158(7): 315-323, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35531305